Head and neck cancer is a category of epithelial malignancies originating in the paranasal sinuses, nasal cavity, oral cavity, pharynx, and larynx. The majority of these epithelial malignancies are squamous cell carcinoma of the head and neck (SCCHN), with tobacco and alcohol consumption being the primary risk factors. Nonetheless, accumulating evidence has identified human papillomavirus (HPV) as a causative factor in particular subsets of squamous cell carcinoma of the head and neck (SCCHN). Approximately two-thirds of individuals with SCCHN exhibit advanced-stage illness, frequently affecting regional lymph nodes. Distant metastases at initial presentation are rare, occurring in approximately 10% of individuals. Treatment decisions in SCCHN are frequently intricate, necessitating the involvement of various specialists, including head and neck surgeons, medical oncologists, radiation oncologists, radiologists, plastic surgeons, and dentists. The primary tumor location, stage, resectability, and patient factors—including swallowing and airway issues, preference for organ preservation, and concurrent conditions—inform the therapeutic strategy.